Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Zentalis Pharmaceuticals Inc (ZNTL)

Zentalis Pharmaceuticals Inc (ZNTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Why Shares of Zentalis Pharmaceuticals Dropped This Week Motley Fool - Fri Jun 2, 2023

A rash of insider selling meant the stock gave back some of its gains from last week.

RHHBY : 31.4000 (+1.45%)
ZNTL : 11.98 (+2.61%)
Newman Ferrara LLP Announces Corporate Governance Investigations of Zentalis Pharmaceuticals, Inc. (ZNTL) Business Wire - Tue Jan 10, 2023

Newman Ferrara LLP announced today that the firm is conducting investigations on behalf of shareholders of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) (“Zentalis” or the “Company”). The investigations...

ZNTL : 11.98 (+2.61%)
Moore Kuehn, PLLC Encourages Investors of Zentalis Pharmaceuticals, Inc. to Contact Law Firm PR Newswire - Thu Dec 29, 2022

/PRNewswire/ -- Moore Kuehn, PLLC, a securities law firm located on Wall Street, is investigating whether certain officers and directors of Zentalis...

ZNTL : 11.98 (+2.61%)
Can Zentalis Pharmaceuticals, Inc. (ZNTL) Climb 170% to Reach the Level Wall Street Analysts Expect? Zacks - Thu Dec 8, 2022

The average of price targets set by Wall Street analysts indicates a potential upside of 170.4% in Zentalis Pharmaceuticals, Inc. (ZNTL). While the effectiveness of this highly sought-after metric is questionable,...

ZNTL : 11.98 (+2.61%)
Zentalis Pharmaceuticals Reports Second Quarter 2022 Financial Results and Operational Update Globe Newswire - Tue Aug 9, 2022

Strengthened leadership team with the appointment of additional industry veterans, including CEO Dr. Kimberly Blackwell and Chairman Dave Johnson Received...

ZNTL : 11.98 (+2.61%)
Zentalis Pharmaceuticals to Participate in the Wedbush PacGrow Healthcare Conference Globe Newswire - Wed Aug 3, 2022

NEW YORK and SAN DIEGO, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company...

ZNTL : 11.98 (+2.61%)
Zentalis Pharmaceuticals, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire - Mon Aug 1, 2022

NEW YORK and SAN DIEGO, Aug. 01, 2022 (GLOBE NEWSWIRE) -- Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company...

ZNTL : 11.98 (+2.61%)
Zentalis Pharmaceuticals Appoints Andrea Paul as General Counsel and Corporate Secretary Globe Newswire - Mon Jun 27, 2022

NEW YORK and SAN DIEGO, June 27, 2022 (GLOBE NEWSWIRE) -- Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company...

ZNTL : 11.98 (+2.61%)
Zentalis Pharmaceuticals Appoints Andrea Paul as General Counsel and Corporate Secretary Globe Newswire - Mon Jun 27, 2022

NEW YORK and SAN DIEGO, June 27, 2022 (GLOBE NEWSWIRE) -- Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company...

ZNTL : 11.98 (+2.61%)
Zentalis Pharmaceuticals Promotes Cofounder Cam Gallagher to President Globe Newswire - Tue May 31, 2022

NEW YORK and SAN DIEGO, May 31, 2022 (GLOBE NEWSWIRE) -- Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company...

ZNTL : 11.98 (+2.61%)

Barchart Exclusives

Stocks Rise Before the Open as Investors Await U.S. Economic Data and Fed Speak, Walmart Earnings on Tap Barchart - 28 minutes ago
June S&P 500 E-Mini futures (ESM24) are up +0.08%, and June Nasdaq 100 E-Mini futures (NQM24) are up +0.17% this morning as investors looked ahead to a new round of U.S. economic data, remarks from Fed officials, and an earnings report from retail giant Walmart. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot